Evidence map›Paper›PMID 34382345›Full record

ArticleJournal of the International AIDS Society2021

Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men.

Vita W Jongen, Thijs Reyniers, Zorah Mh Ypma, Maarten F Schim van der Loeff, Udi Davidovich, Hanne Ml Zimmermann, Liza Coyer, Mark Am van den Elshout, Henry Jc de Vries, Kristien Wouters and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Vita W JongenDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-9538-1501
Thijs ReyniersDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Zorah Mh YpmaDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Maarten F Schim van der LoeffDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Udi DavidovichDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Hanne Ml ZimmermannDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-1647-8485
Liza CoyerDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-5830-2982
Mark Am van den ElshoutDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-0881-5680
Henry Jc de VriesDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Kristien WoutersDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Tom SmekensDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Bea VuylstekeDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-0514-4372
Maria PrinsDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Marie LagaDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Elske HoornenborgDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-0512-2109
GGD Amsterdam · NLInstituut voor Tropische Geneeskunde · BEAmsterdam Neuroscience · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDaily and event-driven PrEP are both efficacious in reducing the risk for HIV infection. However, the practice of event-driven PrEP (edPrEP) is less well studied, in particular when provided as an alternative to daily PrEP. We studied regimen preferences and switches, and sexually transmitted infection (STI) incidence.

methodsWe analysed pooled data from two prospective cohort studies among MSM: Be-PrEP-ared, Belgium and AMPrEP, the Netherlands. In both projects, participants could choose between daily and edPrEP at three-monthly study visits, when they were also screened for sexually transmitted infections including hepatitis C (HCV). We assessed the proportion choosing each regimen, and the determinants of choosing edPrEP at baseline. Additionally, we compared the incidence rates (IRs) of HCV, syphilis and chlamydia or gonorrhoea between regimens using Poisson regression. The study period was from 3 August 2015 until 24 September 2018. RESULTS AND DISCUSSION: We included 571 MSM, of whom 148 (25.9%) chose edPrEP at baseline. 31.7% of participants switched regimen at least once. After 28 months, 23.5% used edPrEP. Older participants (adjusted odds ratio (aOR) = 1.38 per 10 years, 95% confidence interval (CI) = 1.15 to 1.64) and those unemployed (aOR = 1.68, 95% CI = 1.03 to 1.75) were more likely to initially choose edPrEP. IR of HCV and syphilis did not differ between regimens, but the IR of chlamydia/gonorrhoea was higher among daily users (adjusted incidence rate ratio = 1.61, 95% CI = 1.35 to 1.94).

conclusionsA quarter of participants chose edPrEP at baseline and at 28 months this proportion was similar. Although the IR of HCV and syphilis were similar in the two regimens, the lower incidence of chlamydia and gonorrhoea among edPrEP users may suggest that less frequent STI testing of this group could be considered.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesHomosexuality, MaleHumansMaleProspective StudiesSexual Behaviorevent-driven PrEPHIV prevention & controlmen who have sex with menpre-exposure prophylaxissexually transmitted infectionssyphilis

Identifiers

PMID34382345
PMCPMC8358711
OpenAlexW3189754117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.